Physician profile
Ryan Mcgaughey
NPI 1770847154
$6,498.96
in general payments reported to CMS, 2019-2025
35 companies · $418 in 2025
The $418 reported for 2025 was more than what 90% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,102 · 2020: $819 · 2021: $1,679 · 2022: $567 · 2023: $388 · 2024: $1,525 · 2025: $418.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,304 · Travel and Lodging: $1,027.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,303.85 |
| Travel and Lodging | $1,026.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,424.15 | 2019-2025 | General - Pain Management, Intracept, Wavewriter Alpha Prime 16 |
| Amgen INC. | $503.01 | 2019-2022 | |
| Medtronic USA, INC. | $481.46 | 2019-2020 | |
| Medtronic, INC. | $439.08 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $325.20 | 2020-2021 | |
| Scilex Pharmaceuticals INC. | $296.25 | 2019-2022 | |
| Abbvie INC. | $269.97 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $212.42 | 2019-2021 | |
| Lilly USA, LLC | $167.85 | 2019-2022 | |
| Redhill Biopharma INC. | $153.81 | 2021 | |
| Collegium Pharmaceutical, INC. | $139.39 | 2019-2021 | |
| Supernus Pharmaceuticals, INC. | $121.04 | 2019-2021 | |
| Spr Therapeutics, INC | $106.67 | 2020 | |
| Biodelivery Sciences International, INC. | $97.22 | 2019-2021 | |
| Si-Bone, INC. | $86.46 | 2019-2025 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $80.75 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $77.11 | 2020-2021 | |
| Horizon Therapeutics Plc | $69.99 | 2020-2022 | |
| Daiichi Sankyo INC. | $61.27 | 2019 | |
| Grt US Holding, INC. | $55.79 | 2020-2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $55.72 | 2022 | |
| Averitas Pharma INC. | $43.48 | 2023-2024 | Qutenza |
| Allergan, INC. | $31.96 | 2020-2021 | |
| Pfizer INC. | $27.46 | 2020-2021 | |
| Vertos Medical, INC. | $27.39 | 2024 | Mild Device Kit |
| Abbott Laboratories | $18.05 | 2021 | |
| Upsher-Smith Laboratories LLC | $17.54 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $16.07 | 2019 | |
| Zyla Life Sciences, INC. | $15.05 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $14.23 | 2024 | |
| Currax Pharmaceuticals LLC | $13.67 | 2021 | |
| Sentynl Therapeutics, INC. | $13.09 | 2019 | |
| Mdd US Operations, LLC | $12.96 | 2019 | |
| Shionogi INC | $12.30 | 2019 | |
| Djo, LLC | $11.10 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Mcgaughey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.